LICA PHARMACEUTICALS ApS: Financial statements 2024
CVR: 25332520
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 210,297 and a net result of DKK 1,406,816 compared with DKK 1,731,068 the year before. That is a decrease of 10.2% compared with the year before. Equity in the 2024 report amounted to DKK 23,770,576. The solvency ratio was 98.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 210,297
- Profit/Loss
- DKK 1,406,816
- Equity
- DKK 23,770,576
- Total Assets
- DKK 24,158,031
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 210 t. | 1.4 mio. | 23.8 mio. | 1 |
| 2023 | - | 234 t. | 1.7 mio. | 22.4 mio. | 1 |
| 2022 | - | 313 t. | -1.5 mio. | 20.6 mio. | 1 |
| 2021 | - | 371 t. | 2.6 mio. | 22.2 mio. | 1 |
| 2020 | - | 326 t. | 844 t. | 19.6 mio. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
LICA PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK 234,223, and the net result was DKK 1,731,068.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.